Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine
Clinical trial NCT05107115 · COMPLETED
Trial details
- NCT number
- NCT05107115
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-24
- Primary completion
- 2023-07-19
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.